My bookmarksSign up free

Commission Implementing Regulation (EU) 2023/937 of 10 May 2023 correcting Implementing Regulation (EU) 2017/2470 as regards the inclusion of ‘Phosphated distarch phosphate produced from wheat starch’ in the Union list of novel foods (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/937 of 10 May 2023 correcting Implementing Regulation (EU) 2017/2470 as regards the inclusion of ‘Phosphated distarch phosphate produced from wheat starch’ in the Union list of novel foods (Text with EEA relevance)

Implementing Regulation (EU) 2023/937 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) 2017/2470 is corrected in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is corrected as follows: (a) in Table 1 (Authorised novel foods), the following entry is inserted between the entry for ‘Phosphated maize starch’ and the entry for ‘Phosphatidylserine from fish phospholipids’: ‘ Phosphated wheat starch Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be “Phosphated wheat starch”.’   Baked bakery products 15  % Pasta Breakfast cereals Cereal bars (b) in Table 2 (Specifications), the following entry is inserted between the entry for ‘Phosphated maize starch’ and the entry for ‘Phosphatidylserine from fish phospholipids’: ‘ Phosphated wheat starch Description: Phosphated distarch phosphate produced from wheat starch (phosphated wheat starch) is a chemically modified resistant starch derived from wheat starch by combining chemical treatments to create phosphate cross-links within and between individual starch molecules. The novel food ingredient is a white or near white free flowing powder. Characteristic/Composition: CAS No: 11120-02-8 Chemical formula: (C 6 H 10 O 5 ) n [(C 6 H 9 O 5 ) 2 PO 2 H] x [(C 6 H 9 O 5 )PO 3 H 2 ] y n = number of glucose units; x, y = degrees of substitution Parameter Powder form 1 Powder form 2 Phosphated Distarch Phosphate (Dry basis) ≥ 85  % ≥ 75  % Unmodified Wheat Starch (Dry basis) ≤ 15  % ≤ 25  % Moisture 9 -12  % Total dietary fibre (dry matter basis) ≥ 76,0  % ≥ 66,0  % Ash ≤ 3  % Protein ≤ 0,5  % Total fat ≤ 0,50  % ≤ 0,34  % Residual bound phosphorus ≤ 0,4  % (as phosphorus) pH (25 % slurry) 4,5 – 6,5 Heavy metals: Arsenic: ≤ 1 mg/kg Lead: ≤ 2 mg/kg Mercury: ≤ 0,1  mg/kg Microbiological criteria: Total viable aerobic counts: ≤ 10 4 CFU/g Total yeast and mould count: ≤ 200 CFU/g Escherichia coli : Negative to test Salmonella spp.: Negative to test CFU: Colony Forming Units’

Other acts of the same type
Commission Implementing Regulation (EU) 2019/717 of 8 May 2019 renewing the approval of the active substance isoxaflutole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/706 of 7 May 2019 renewing the approval of the active substance carvone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/699 of 6 May 2019 laying down technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from 31 March 2019 until 29 June 2019 in accordance with Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/696 of 3 May 2019 amending for the 301st time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Implementing Regulation (EU) 2019/705 of 2 May 2019 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2019/723 of 2 May 2019 laying down rules for the application of Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the standard model form to be used in the annual reports submitted by Member States (Text with EEA relevance.)Commission Regulation (EU) 2019/680 of 30 April 2019 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.)Commission Regulation (EU) 2019/681 of 30 April 2019 amending Annex II to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.)Commission Regulation (EU) 2019/698 of 30 April 2019 amending Annexes III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/716 of 30 April 2019 amending Implementing Regulations (EU) No 22/2013 and (EU) No 540/2011 as regards the conditions of approval of the active substance cyflumetofen (Text with EEA relevance.)Council Implementing Regulation (EU) 2019/672 of 29 April 2019 implementing Regulation (EU) No 401/2013 concerning restrictive measures in respect of Myanmar/Burma

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next